Yahoo News: Cancer

US jury hits Takeda, Eli Lilly with $9B penalty

Tue, 04/08/2014 - 14:35
TOKYO (AP) — A U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly and Co., to pay $9 billion in punitive damages over a diabetes medicine linked to cancer. The drug companies said Tuesday they will "vigorously challenge" the decision.

Roche buys rights to Oryzon's cancer-suppressing gene drug

Mon, 04/07/2014 - 10:28
Roche has bought the rights to an experimental drug from Spain's Oryzon Genomics that can switch on genes to block cancer growth, as the Swiss drugmaker looks to maintain its dominance in the lucrative field of oncology. The world's largest maker of cancer drugs will pay Barcelona-based Oryzon $21 million in upfront and near-term milestone payments and could pay out more than $500 million if the ...

Pfizer reports promising results for cancer drug

Sun, 04/06/2014 - 23:42
WASHINGTON (AP) — An experimental drug has shown encouraging results in treating advanced breast cancer in an early clinical trial, pharmaceutical giant Pfizer reported Sunday.

Community taking a dive for young cancer patient

Sun, 04/06/2014 - 16:27
KANSAS CITY, Mo. (AP) — Being told to "go jump in a lake" is usually a snarky kiss-off. But it's become a heartwarming call-to-action for a Missouri community whose effort to help the family of a 5-month-old boy with cancer has inspired thousands across the country to submerge themselves in cold bodies of water.

Agios leukemia drug shows promise in tiny, early study

Sun, 04/06/2014 - 14:31
An experimental drug being developed by Agios Pharmaceuticals Inc showed promising anti-cancer activity in a tiny Phase I study of patients with relapsed acute myeloid leukemia (AML), according to data presented on Sunday. Three of them achieved complete remission and two achieved complete remission with incomplete platelet recovery, meaning that the leukemia had exited their bone marrow but the ...

Pfizer drug doubles time to breast cancer tumor growth in trial

Sun, 04/06/2014 - 14:30
Pfizer Inc's experimental breast cancer drug in a clinical trial nearly doubled the amount of time patients lived without their disease getting worse, but overall survival was not yet shown to be statistically significant, researchers said. The Phase 2 study, which involved women with the most common form of breast cancer, found that those treated with hormone drug letrozole plus Pfizer's ...

Meet the CyberKnife, a Cancer-Fighting Robot That Gave a Man His Voice Back

Sun, 04/06/2014 - 08:10
Cancer takes a toll on everyone it afflicts, but vocal cord cancer patients often pay a particularly high price: They lose their voice. Earlier this year, Stephen Wiley, 59, became the world’s first-known patient to be treated for vocal cord tumors with the CyberKnife, a $7 million device built by the California-based company Accuray. Wiley’s cancer had reduced his voice to a whisper when he ...

Amgen melanoma drug fails to improve overall survival rates

Fri, 04/04/2014 - 15:34
(Reuters) - Amgen Inc said its experimental drug to treat a deadly form of skin cancer did not significantly improve overall survival rates in patients enrolled in a late-stage study. The company said the drug met the study's main goal of shrinking tumors, as it had previously reported, but did not meet the secondary goal of improving overall survival in patients with melanoma. ISI Group analyst ...

Halozyme suspends pancreatic cancer study, shares plunge

Fri, 04/04/2014 - 13:41
(Reuters) - Halozyme Therapeutics Inc said it had halted enrolment of patients and dosing of its cancer drug in a mid-stage trial for the treatment of pancreatic cancer, after the recommendation of an independent safety committee. The biotechnology company said the panel was assessing a possible difference in the rate of blood clots found in patients receiving its treatment against those ...

Mom Succumbs to Cancer 6 Weeks After Giving Birth

Thu, 04/03/2014 - 23:17
Elizabeth Joice Decided Not to Abort Pregnancy for Cancer Treatment

Roche lung cancer pill gets reprieve in UK reversal

Thu, 04/03/2014 - 23:08
Britain's health cost watchdog NICE on Friday reversed an earlier decision to limit the use of Roche's Tarceva cancer pill on the state health service in a move the drugmaker said would help around 2,000 patients a year. New draft guidance from the National Institute for Health and Clinical Excellence (NICE) now backs use of Tarceva for people with non-small-cell lung cancer that has progressed ...

Obama signs cancer research bill in memory of girl

Thu, 04/03/2014 - 22:00
A 10-year-old girl who died of brain cancer is leaving a legacy for other sick children in a new law signed by President Barack Obama. Obama on Thursday signed the bipartisan Gabriella Miller Kids First ...

Obama signs cancer research bill in memory of girl

Thu, 04/03/2014 - 20:24
WASHINGTON (AP) — A 10-year-old girl who died of brain cancer is leaving a legacy for other sick children in a new law signed by President Barack Obama.

Fertility drugs not tied to long term breast cancer risk

Thu, 04/03/2014 - 12:19
By Andrew M. Seaman NEW YORK (Reuters Health) - Despite concerns and some evidence that fertility treatments increase a woman's chances of developing breast cancer, a large, long term study finds no added risk. Nearly 10,000 women who received drugs to stimulate ovulation were no more likely to develop breast cancer during 30 years of follow-up than those who never used the drugs, researchers ...

Report: EPA fails to disclose risks in human tests

Thu, 04/03/2014 - 11:54
An internal investigation issued Wednesday found that the Environmental Protection Agency failed to disclose long-term cancer risks and a small chance of death to 81 human test subjects who consented to ...

Fukushima meltdown not seen causing many cancers: UN scientists

Wed, 04/02/2014 - 17:40
By Fredrik Dahl VIENNA (Reuters) - Japan's Fukushima nuclear disaster is unlikely to lead to a rise in the number of people developing cancer like after Chernobyl in 1986, even though the most exposed children may face an increased risk, U.N. scientists said on Wednesday. In a major study, the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) said it did not expect ...

Living Alone Linked with Higher Risk of Melanoma Death in Men

Wed, 04/02/2014 - 15:41
Men who live alone may have a higher risk of dying from the skin cancer melanoma compared with men who live with a partner, a new study from Sweden finds. Studies have shown that 40 to 60 percent of melanoma cases are discovered by patients themselves or their family members, the researchers said. It is possible that women are more aware than men of skin health messages and signs of skin cancer ...

GlaxoSmithKline throws in towel on lung cancer vaccine trial

Wed, 04/02/2014 - 08:08
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline Plc (GSK) has stopped a high-profile clinical trial using a novel vaccine to fight lung cancer after deciding it will not be possible to find a sub-group of patients who might benefit. The decision comes less than two weeks after GSK said the MAGE-A3 therapeutic vaccine did not help patients with non-small cell lung cancer in the Phase III ...

Breast cancer screening a complex mix of benefits, risk -report

Tue, 04/01/2014 - 23:47
By Andrew M. Seaman NEW YORK (Reuters Health) - A review of 50 years of studies on the risks and benefits of yearly mammograms has tied them to a 19 percent drop overall in breast cancer deaths, but whether a woman benefits depends on factors such as age and family history, U.S. researchers said on Tuesday. A report published in the Journal of the American Medical Association is the latest ...

What a Mammogram Could Do for You: Study Lays Out Risk & Benefits

Tue, 04/01/2014 - 23:05
To maximize the benefits and lower the risks of routine mammograms for breast cancer screening, it's best to base decisions on each woman's individual risk level, as well as her values and priorities, researchers concluded after reviewing 50 years of studies on mammograms. Mammography is performed routinely with the goal of catching breast cancer early, but it is unclear if early diagnosis is ...